Viking Therapeutics
VKTX
24.77
-1.07
-4.14%
Viking Therapeutics
US · VKTX
#2352 by market cap
Listed 2015
24.77
-1.07
-4.14%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:56
About Viking Therapeutics
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
- Founded
- 2012
- CEO
- Dr. Brian Lian, PhD
- Employees
- 53
- Headquarters
- San Diego, California, United States of America
- Fiscal year end
- 12-31
- Website
- vikingtherapeutics.com
Company profile
- Exchange
- US
- Symbol
- VKTX
- Market-cap rank
- #2352
- Listing date
- 2015-04-29
- Market cap
- 3.16B
- Float cap
- 3.09B
- Shares out
- 127.52M
- Float shares
- 124.60M
Sectors & themes
Quote time 2026-11-20 19:56:05 · For reference only, not investment advice and not tailored to your situation.
Viking Therapeutics discussion 0 comments